Improving Access to Medications for Opioid Use Disorder
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
This project helps addiction treatment centers offer more effective medications to people with opioid use disorder.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11126897 on NIH RePORTER |
What this research studies
Many people with opioid use disorder struggle to find treatment centers that offer medications like buprenorphine. This project works with 72 community addiction treatment programs to help them successfully provide these important medications. We will use a step-by-step approach, starting with monitoring and feedback, then offering workshops on improving treatment processes, and finally providing more intensive support if needed. Our goal is to make sure more people can get the medication-assisted treatment they need.
Who could benefit from this research
Good fit: Patients who could benefit are those living with opioid use disorder who are seeking treatment at community addiction programs.
Not a fit: Patients who are not seeking treatment for opioid use disorder or who are already receiving comprehensive medication-assisted treatment may not directly benefit from this specific effort.
Why it matters
Potential benefit: If successful, this work could significantly increase the number of addiction treatment programs offering life-saving medications for opioid use disorder, making it easier for patients to access care.
How similar studies have performed: Previous efforts in implementation science and process improvement strategies like NIATx have shown success in helping organizations adopt evidence-based practices.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Mcgovern, Mark P — Stanford University
- Study coordinator: Mcgovern, Mark P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.